Meticulous Research®, a leading market research company, has published a report titled, “Europe NGS Automation Market by Product (Platform, Consumables), Sequencing Type (Whole Genome, Exome, Targeted), Application (Drug Discovery, Diagnostics), End User (Hospitals, Diagnostic Laboratories, Pharmaceutical, Academic) - Forecast to 2030.”

The report projects that the NGS (Next-Generation Sequencing) automation market in Europe will reach $380.4 million by 2030, growing at a compound annual growth rate (CAGR) of 13.4% from 2024 to 2030. This growth is attributed to increasing R&D activities in life sciences, heightened demand for NGS automation in laboratories, and the rising prevalence of chronic diseases like cancer.

Additional growth drivers include expanding applications of next-generation sequencing and a growing number of partnerships aimed at developing library preparation protocols. However, the high cost of automation workstations may limit market adoption, while regulatory and standardization issues in diagnostic testing and the need for highly skilled personnel pose further challenges.

Download Free Sample Research PDF @ https://www.meticulousresearch.com/download-sample-report/cp_id=5644

Market Segmentation and Future Outlook:
The European NGS automation market is analyzed based on product, application, sequencing type, and end user, with evaluations at the country level.

• Product: In 2024, the workstation/robotic platform segment is expected to hold the largest market share. This segment’s dominance is driven by the rising demand for NGS automation solutions in laboratories and the advantages of automation over manual processes during library preparation.
• Application: The clinical diagnostic segment is projected to experience the highest growth rate during the forecast period. This growth is fueled by the increasing use of NGS by diagnostic laboratories for diagnosing rare genetic disorders, precision oncology, and pathogen detection in infectious diseases.
• Sequencing Type: Whole genome sequencing is anticipated to account for the largest share of the market in 2024. The segment’s leading position is attributed to the demand for NGS automation solutions to reduce per sample costs.
• End User: Pharmaceutical and biotechnology companies are expected to lead the market in 2024. This is due to higher R&D expenditures, increased demand for new drug development, and the financial resources to invest in sophisticated NGS automation workstations.

Quick Buy – Europe NGS Automation Market –Opportunity Analysis and Industry Forecast (2024-2030), Research Report: https://www.meticulousresearch.com/Checkout/76016768

Key Players:
Major companies in the European NGS automation market include Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Eppendorf AG (Germany), Hamilton Company (U.S.), PerkinElmer, Inc. (U.S.), Tecan Group Ltd. (Switzerland), PRIMADAG SAS (France), BRAND GMBH + CO KG (Germany), Hudson Robotics (U.S.), SPT Labtech (U.K.), Thermo Fisher Scientific Inc. (U.S.), and F. Hoffmann-La Roche AG (Switzerland).

Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research